Patients don't end up paying the list price of any drug, and the cost could vary depending on insurance plans and how much the person spent on health care that year. But the Senate joined in the push on Thursday, doling out $1 million to HHS to implement transparency regulations.

from Kaiser Health News https://ift.tt/2OYXSqe

Related Posts:

0 comments:

Post a Comment

Popular Posts